Squarepoint
RLYB icon

Squarepoint’s Rallybio RLYB Stock Holding History

Squarepoint’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-4,159
Closed -$21.8K – 4975
2025
Q1 		$21.8K Buy
4,159
+2,016
+94% +$12.7K ﹤0.01% 4432
2024
Q4 		$16.5K Sell
2,143
-153
-7% -$1.28K ﹤0.01% 4945
2024
Q3 		$21.5K Sell
2,296
-1,694
-42% -$16.3K ﹤0.01% 4019
2024
Q2 		$42.8K Sell
3,990
-563
-12% -$7.63K ﹤0.01% 3921
2024
Q1 		$67.4K Buy
4,553
+2,798
+159% +$39K ﹤0.01% 3846
2023
Q4 		$33.5K Buy
1,755
+480
+38% +$11.7K ﹤0.01% 3880
2023
Q3 		$34.4K Buy
+1,275
New +$55.2K ﹤0.01% 3666
2023
Q1 		– Sell
-1,646
Closed -$86.5K – 3725
2022
Q4 		$86.5K Buy
+1,646
New +$97.1K ﹤0.01% 2986

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return

Squarepoint's RLYB Position: Q2 2025 in Review

Squarepoint sold out of Rallybio (RLYB) in Q2 2025, closing a stake of 4,159 shares — an estimated $21.8K sold.

Squarepoint first reported a position in RLYB in Q4 2022 and held it in 8 quarters. The position peaked at $86.5K in Q4 2022. 48 funds tracked by Wall St. Rank hold RLYB as of Q2 2025.

  • Squarepoint reported no remaining Rallybio position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 4,159 Rallybio shares in Q2 2025, an estimated $21.8K.
  • Squarepoint first reported a position in Rallybio in Q4 2022 and held it in 8 quarters.
  • Squarepoint's Rallybio position peaked at $86.5K in Q4 2022.
  • 48 funds tracked by Wall St. Rank held Rallybio as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.